The largest community of pharma leaders

Avivagen Announces Officer Changes

OTTAWA, Ontario–(BUSINESS WIRE)–Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces the appointments of Mr. Kym Anthony to the position of C.E.O. and Mr. Jeffrey Kraws, a director of the Corporation, to the position of Chairman of the Board. Mr. Anthony previou

Recent Articles